Search Results - "KROISS, Matthias"

Refine Results
  1. 1

    Update in Adrenocortical Carcinoma by Fassnacht, Martin, Kroiss, Matthias, Allolio, Bruno

    “…Adrenocortical carcinoma (ACC) is an orphan malignancy that has attracted increasing attention during the last decade. Here we provide an update on advances in…”
    Get full text
    Journal Article
  2. 2

    Personalized Management of Pheochromocytoma and Paraganglioma by Nölting, Svenja, Bechmann, Nicole, Taieb, David, Beuschlein, Felix, Fassnacht, Martin, Kroiss, Matthias, Eisenhofer, Graeme, Grossman, Ashley, Pacak, Karel

    Published in Endocrine reviews (01-04-2022)
    “…Abstract Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape that allows their assignment to clusters based on underlying…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma by Schweitzer, Sophie, Kunz, Meik, Kurlbaum, Max, Vey, Johannes, Kendl, Sabine, Deutschbein, Timo, Hahner, Stefanie, Fassnacht, Martin, Dandekar, Thomas, Kroiss, Matthias

    Published in European journal of endocrinology (01-02-2019)
    “…Objective Current workup for the pre-operative distinction between frequent adrenocortical adenomas (ACAs) and rare but aggressive adrenocortical carcinomas…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    The role of regulated necrosis in endocrine diseases by Tonnus, Wulf, Belavgeni, Alexia, Beuschlein, Felix, Eisenhofer, Graeme, Fassnacht, Martin, Kroiss, Matthias, Krone, Nils P., Reincke, Martin, Bornstein, Stefan R., Linkermann, Andreas

    Published in Nature reviews. Endocrinology (01-08-2021)
    “…The death of endocrine cells is involved in type 1 diabetes mellitus, autoimmunity, adrenopause and hypogonadotropism. Insights from research on basic cell…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Inhibition of Cholesterol Esterification in the Adrenal Gland by ATR101/PD132301–2, A Promising Case of Drug Repurposing by Kroiss, Matthias, Fassnacht, Martin

    Published in Endocrinology (Philadelphia) (01-05-2016)
    “…Adrenocortical carcinoma (ACC) is a malignancy that harbors a significant risk of recurrence even after complete resection and has a particularly unfavorable…”
    Get full text
    Journal Article
  12. 12

    SOAT1: A Suitable Target for Therapy in High-Grade Astrocytic Glioma? by Löhr, Mario, Härtig, Wolfgang, Schulze, Almut, Kroiß, Matthias, Sbiera, Silviu, Lapa, Constantin, Mages, Bianca, Strobel, Sabrina, Hundt, Jennifer Elisabeth, Bohnert, Simone, Kircher, Stefan, Janaki-Raman, Sudha, Monoranu, Camelia-Maria

    “…Targeting molecular alterations as an effective treatment for isocitrate dehydrogenase-wildtype glioblastoma (GBM) patients has not yet been established…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Endocrine side effects of cancer immunotherapy by Kroiß, Matthias, Schilling, Bastian, Deutschbein, Timo

    Published in Deutsche medizinische Wochenschrift (1946) (01-12-2020)
    “…Immune checkpoint inhibitors (ICI) have become a cornerstone in the treatment of various human malignancies. Immune-related adverse events (irAE) are common…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma by Landwehr, Laura-Sophie, Altieri, Barbara, Schreiner, Jochen, Sbiera, Iuliu, Weigand, Isabel, Kroiss, Matthias, Fassnacht, Martin, Sbiera, Silviu

    Published in Journal for immunotherapy of cancer (01-05-2020)
    “…Adrenocortical carcinoma (ACC) is a rare endocrine malignancy. Tumor-related glucocorticoid excess is present in ~60% of patients and associated with…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Simulation-Based Interpretation of Therapeutically Monitored Cabozantinib Plasma Concentration in Advanced Adrenocortical Carcinoma with Hemodialysis by Zimmermann, Sebastian, Kurlbaum, Max, Mayer, Stefanie, Fassnacht, Martin, Kroiss, Matthias, Scherf-Clavel, Oliver

    Published in Therapeutic drug monitoring (01-10-2021)
    “…Adrenocortical carcinoma is an orphan but aggressive malignancy with limited treatment options. Cabozantinib (CAB), a tyrosine kinase inhibitor, has emerged as…”
    Get full text
    Journal Article